Cefpodoxime + Clavulanic Acid

Combinations of Cefpodoxime + Clavulanic Acid


  • Cefpodoxime 200 mg. & Clavulanic Acid 125 mg. Tablets
  • Cefpodoxime 100 mg. & Clavulanic Acid 62.5 mg. Tablets
  • Cefpodoxime 50 mg. & Clavulanic Acid 31.25 mg. Tablets
  • Cefpodoxime 50 mg. & Clavulanic Acid 31.25 mg. per 5 ml. Dry Syrup

Cefpodoxime 200mg + Clavulanic Acid 125 mg: A Combination of Cefpodoxime (third generation oral cephalosporin) and a beta lactamase inhibitor, Clavulanic Acid, used for the treatment of urinary tract infections, pneumonia, bronchitis, gonorrhea, and multiple other infections (see INDICATIONS).

EXECUTIVE SUMMARY
Drug Name Cefpodoxime + Clavulanic Acid
Mechanism of Action

Cefpodoxime: Inhibition of cell wall synthesis

Clavulanic Acid: Enzyme inhibitor that enhances the antibacterial activity

Indication Multiple Infections (see INDICATIONS)
Form
  • Tablets (Cefpodoxime/Clavulanic Acid): 200 mg/125 mg
  • Tablets (Cefpodoxime/Clavulanic Acid): 100 mg/62.5 mg
  • Dry Syrup (Cefpodoxime/Clavulanic Acid): 100 mg/62.5 mg
  • Dry Syrup (Cefpodoxime/Clavulanic Acid): 50 mg/32.25 mg